Literature DB >> 9763187

Voice changes in women treated for endometriosis and related conditions: the need for comprehensive vocal assessment.

M A Pattie1, B E Murdoch, D Theodoros, K Forbes.   

Abstract

Hormonal treatments which have an androgenic effect have the potential to cause vocal changes. The changes in vocal fold structure and voice quality are considered to be irreversible. To date, studies have documented subjective vocal changes or documented single cases without detailed, baseline voice assessments. The impact on laryngeal function of women taking these androgenic treatments requires further detailed, objective assessment. The need for increased awareness of the actions of androgenic hormones on womens' voices, and the benefits of a thorough voice assessment are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9763187     DOI: 10.1016/s0892-1997(98)80027-1

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  4 in total

1.  The Protective Effect of Echinochrome A on Extracellular Matrix of Vocal Folds in Ovariectomized Rats.

Authors:  Ji Min Kim; Jeong Hun Kim; Sung-Chan Shin; Gi Cheol Park; Hyung Sik Kim; Keunyoung Kim; Hyoung Kyu Kim; Jin Han; Natalia P Mishchenko; Elena A Vasileva; Sergey A Fedoreyev; Valentin A Stonik; Byung-Joo Lee
Journal:  Mar Drugs       Date:  2020-01-24       Impact factor: 5.118

2.  Detection of hormone receptors in the human vocal fold.

Authors:  Ch Voelter; N Kleinsasser; P Joa; I Nowack; R Martínez; R Hagen; H U Voelker
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-10       Impact factor: 2.503

3.  Effect of testosterone therapy on the female voice.

Authors:  R Glaser; A York; C Dimitrakakis
Journal:  Climacteric       Date:  2016-02-09       Impact factor: 3.005

4.  Impact of early postnatal androgen exposure on voice development.

Authors:  Leila Grisa; Maria L Leonel; Maria I R Gonçalves; Francisco Pletsch; Elis R Sade; Gislaine Custódio; Ivete P S Zagonel; Carlos A Longui; Bonald C Figueiredo
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.